NCT04503369 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Cooper SJ, Cant RP
Measuring non-technical skills of medical emergency teams: an update on the validity and reliability of the Team Emergency Assessment Measure (TEAM). Resuscitation. 2014 Jan;85(1):31-3. doi: 10.1016/j.resuscitation.2013.08.276. Epub 2013 Sep 12.
Napier F, Davies RP, Baldock C, Stevens H, Lockey AS, Bullock I, Perkins GD
Validation for a scoring system of the ALS cardiac arrest simulation test (CASTest). Resuscitation. 2009 Sep;80(9):1034-8. doi: 10.1016/j.resuscitation.2009.04.043. Epub 2009 Jun 13.
PERAN, D
, KUBALOVÁ, J..: Observation of non-technical skills during resuscitation (Sledování netechnických dovedností pri resuscitaci) [article in Czech language]. Urgentní medicína: Casopis pro neodkladnou lékarskou péci. Mediprax CB s.r.o., 2017 (4). ISSN 1212-1924.

Observation of Non-technical Skills (e.g. Communication, Team Leader Skills, Teamwork, Situational Awareness Etc.) in the Pre-hospital Care in the Czech Republic

Details for clinical trial NCT04503369

Clinical trial NCT04503369 - References